Durham, North Carolina, December 1st, 2022 – The NC Tech Awards has named Pro-ficiency as one of the Top Ten Tech Startups to Watch of 2022. This award signifies the innovative progress Pro-ficiency has made, and the potential for further success and expansion in 2023...

Pro-ficiency announced today the launch of Pro-Active Protocol, a unique and proprietary protocol optimization methodology that applies simulation to visually represent the study operational flow.

Durham, North Carolina, July 12th, 2022 - Pro-ficiency announces the acquisition of all life sciences intellectual property and the associated team of Fugitive Labs, a full-service nationwide product development firm. This acquisition significantly increases...

Durham, North Carolina, June 23rd, 2022 - Pro-ficiency completes its strategic board expansion initiative with the appointment of Jeanne Hecht to the organization's Board of Directors. "Considering Jeanne's reputation as a visionary in clinical trials, her appointment...

Pro-ficiency continues to expand its thought leadership representation on their Board of Directors with the addition of Robin Newman, RN, MSN, EdD, CPNP. 

Pro-ficiency, a pioneer in the field of simulation-based training in clinical trials, has opened up a select number of seats on the Company’s Board of Directors. Dr. Jeffrey Kasher, a renowned visionary in clinical trials with over 28 years of experience at organizations like Eli Lilly, is the first to join as the newest Director. 

Pro-ficiency was selected as a participant in the DPharm Idol Disrupt program, hosted at the Disruptive Innovations conference September 28-29, 2021. RALEIGH N.C. – FOR IMMEDIATE RELEASE: [September 30, 2021] Idol Disrupt, now in its 11th year, aims at featuring...